IVM
OCRX

InterWest Venture Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

InterWest Venture Management’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,248,064
Closed -$2.62M – 14
2016
Q4 		$2.62M Buy
+1,248,064
New +$2.91M 0.62% 10

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

InterWest Venture Management's OCRX Position: Q1 2017 in Review

InterWest Venture Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 1,248,064 shares — an estimated $2.62M sold.

InterWest Venture Management first reported a position in OCRX in Q4 2016 and held it in 1 quarter. The position peaked at $2.62M in Q4 2016. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

  • InterWest Venture Management reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • InterWest Venture Management sold 1,248,064 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $2.62M.
  • InterWest Venture Management first reported a position in Ocera Therapeutics, Inc. in Q4 2016 and held it in 1 quarter.
  • InterWest Venture Management's Ocera Therapeutics, Inc. position peaked at $2.62M in Q4 2016.
  • 26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on InterWest Venture Management's 13F filing for Q1 2017, filed 14 Apr 2017.